IRVINE, Calif., and ADDISON, Texas, Nov. 8 /PRNewswire-FirstCall/ -- Cardiac Science, Inc. , a leading manufacturer of life-saving automatic public-access defibrillators (AEDs), and Concentra Inc., a comprehensive healthcare services provider serving industry and group health care markets, announced today a strategic distribution relationship whereby the sales organizations of both companies will jointly market Cardiac Science AEDs, associated AED/CPR training and program management services to Concentra customers. Concentra Health Services customer base includes more than 120,000 U.S. corporations.
“Our 300-member sales organization, comprised of health services managers, account managers and national account managers, field inquiries from our customers about deploying AEDs in the workplace,” said Keith Newton, President of Concentra Health Services. “This partnership allows us to offer the best in class Powerheart(R) AED as well as training and program management services to our customers. We view workplace defibrillation programs as highly complementary to our core employee wellness services.”
Raymond W. Cohen, Chairman and CEO of Cardiac Science, commented on the partnership by stating, “Corporate executives are fast becoming aware that the availability of AEDs in the workplace is not only an important employee benefit, but is also a great means of risk mitigation for the company.”
“As a leader in workplace healthcare services, Concentra has an established reach into thousands of U.S. corporations, which we believe is one of the most under penetrated AED market segments and where Cardiac Science has the ideal product and service offering,” continued Cohen. “Concentra has a unique relationship with its customers and we anticipate this will open up a new marketing channel for AEDs in the workplace. We look forward to working with the Concentra sales team as partners in expanding our reach and in helping corporations establish safe work environments.”
About Concentra Inc.
Concentra Inc. is the comprehensive outsourcing solution for containing healthcare and disability costs. Serving the occupational, auto and group healthcare markets, Concentra provides employers, insurers and payors with a variety of integrated healthcare services. These services include employment-related injury and occupational healthcare, in-network and out-of- network medical claims review and re-pricing, access to specialized preferred provider organizations, first notice of loss services, case management and other cost containment services. Concentra is a registered trademark of Concentra Operating Corporation. All rights reserved. http://www.concentra.com/
About Concentra Health Services, Inc.(R)
Headquartered in Addison, Texas, Concentra Health Services, Inc. is a leading healthcare company offering a broad range of services that provide quality patient care for work-related injuries while containing the rising costs of occupational healthcare and workers’ compensation. The company operates over 250 occupational medical centers, in 84 markets, and 34 states. Concentra Health Services, Inc., is a wholly owned subsidiary of Concentra Inc. Copyright 2004 Concentra Operating Corporation. All rights reserved. http://www.concentra.com/
About Cardiac Science
Cardiac Science develops, manufactures and markets Powerheart(R)-brand public-access defibrillators (AEDs) and offers comprehensive AED/CPR training and AED program management services that facilitate successful deployments. The Company also makes the Powerheart(R) CRM(TM), the only FDA-cleared therapeutic patient monitor that instantly and automatically treats hospitalized cardiac patients who suffer life-threatening heart rhythms. In addition, its 55-person sales force in the U.S. and independent distributors in over 40 countries, Cardiac Science also manufactures its AED products on a private label basis for other leading medical companies such as Nihon Kohden (Japan), Quinton Cardiology Systems and GE Healthcare. For more information, please visit http://www.cardiacscience.com/.
This news release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. In addition, from time to time the company, or its representatives, have made or may make forward looking statements orally or in writing. The words “estimate,” “potential,” “intended,” “expect,” “anticipate,” “believe,” and similar expressions or words are intended to identify forward looking statements. Such forward-looking statements include, but are not limited to the achievement of future revenue growth based on the co-marketing alliance with Concentra. Cardiac Science cautions that these statements are subject to substantial risks and uncertainties and are qualified by important factors that could cause actual results to differ materially from those reflected by the forward-looking statements and should not be relied upon by investors when making an investment decision. Information on these and other factors is detailed in the Company’s Form 10-K for the year ending December 31, 2003, subsequent quarterly filings, and other documents filed by the Company with the Securities and Exchange Commission.
For further information please contact: investors, Matt Clawson, matt@allencaron.com, or media, Len Hall, len@allencaron.com, both of Allen & Caron Inc, +1-949-474-4300, for Cardiac Science, Inc.; or Michael Gioffredi, Chief Marketing Officer of Cardiac Science, Inc., +1-949-797-3800, mgioffredi@cardiacscience.com.
Cardiac Science, Inc.; Concentra Inc.
CONTACT: investors, Matt Clawson, matt@allencaron.com, or media, LenHall, len@allencaron.com, both of Allen & Caron Inc, +1-949-474-4300, forCardiac Science, Inc.; or Michael Gioffredi, Chief Marketing Officer ofCardiac Science, Inc., +1-949-797-3800, mgioffredi@cardiacscience.com
Web site: http://www.concentra.com/
Web site: http://www.cardiacscience.com/